T1	Disorder 0 30	Neuroleptic malignant syndrome
N1 	Reference T1 UMLS:C0027849	Neuroleptic malignant syndrome
T3	Disorder 35 53	serotonin syndrome
N2 	Reference T3 UMLS:C0024586	serotonin syndrome
N3 	Reference T3 UMLS:C0699828	serotonin syndrome
T4	Disorder 99 117	Serotonin syndrome
N4 	Reference T4 UMLS:C0024586	Serotonin syndrome
N5 	Reference T4 UMLS:C0699828	Serotonin syndrome
T5	Disorder 127 157	neuroleptic malignant syndrome
N6 	Reference T5 UMLS:C0027849	neuroleptic malignant syndrome
T6	Disorder 159 162	NMS
N7 	Reference T6 UMLS:C0270699	NMS
N8 	Reference T6 UMLS:C0027849	NMS
T8	Pharmacological_substance 382 400	neuroleptic agents
N1000 	Reference T8 MeSH:D014150	neuroleptic agents
T10	Pharmacological_substance 441 452	venlafaxine
N1001 	Reference T10 MeSH:D000069470	venlafaxine
T11	Pharmacological_substance 454 464	topiramate
N1002 	Reference T11 MeSH:C052342	topiramate
T12	Pharmacological_substance 466 483	divalproex sodium
N1003 	Reference T12 MeSH:D014635	divalproex sodium
T13	Pharmacological_substance 485 496	risperidone
N1004 	Reference T13 MeSH:D018967	risperidone
T14	Pharmacological_substance 502 515	carbamazepine
N1005 	Reference T14 MeSH:D002220	carbamazepine
T15	Pharmacological_substance 870 884	cyproheptadine
N1006 	Reference T15 MeSH:D003533	cyproheptadine
T16	Pharmacological_substance 896 906	dantrolene
N1007 	Reference T16 MeSH:D003620	dantrolene
T17	Pharmacological_substance 930 943	bromocriptine
N1008 	Reference T17 MeSH:D001971	bromocriptine
T18	Pharmacological_substance 971 985	chlorpromazine
N1009 	Reference T18 MeSH:D002746	chlorpromazine
T19	Pharmacological_substance 1029 1042	bromocriptine
N1010 	Reference T19 MeSH:D001971	bromocriptine
T20	Pharmacological_substance 1122 1140	serotonergic agent
N1011 	Reference T20 MeSH:D017366	serotonergic agent
T2	Disorder 1260 1262	SS
N9 	Reference T2 UMLS:C0024586	SS
N10 	Reference T2 UMLS:C0699828	SS
T21	Disorder 1267 1270	NMS
N11 	Reference T21 UMLS:C0270699	NMS
N12 	Reference T21 UMLS:C0027849	NMS
T22	Pharmacological_substance 1542 1554	psychotropic
N1012 	Reference T22 MeSH:D011619	psychotropic
T25	Disorder 1094 1097	NMS
N13 	Reference T25 UMLS:C0270699	NMS
N14 	Reference T25 UMLS:C0027849	NMS
T26	Disorder 1099 1101	SS
N15 	Reference T26 UMLS:C0024586	SS
N16 	Reference T26 UMLS:C0699828	SS
T27	Disorder 911 914	NMS
N17 	Reference T27 UMLS:C0270699	NMS
N18 	Reference T27 UMLS:C0027849	NMS
T28	Disorder 1006 1009	NMS
N19 	Reference T28 UMLS:C0270699	NMS
N20 	Reference T28 UMLS:C0027849	NMS
T29	Disorder 650 652	SS
N21 	Reference T29 UMLS:C0024586	SS
N22 	Reference T29 UMLS:C0699828	SS
T30	Disorder 653 656	NMS
N23 	Reference T30 UMLS:C0270699	NMS
N24 	Reference T30 UMLS:C0027849	NMS
T31	Pharmacological_substance 365 377	serotonergic
T9	Disorder 539 541	SS
N25 	Reference T9 UMLS:C0024586	SS
N26 	Reference T9 UMLS:C0699828	SS
T32	Disorder 542 545	NMS
N27 	Reference T32 UMLS:C0270699	NMS
N28 	Reference T32 UMLS:C0027849	NMS
T33	Disorder 119 121	SS
N29 	Reference T33 UMLS:C0024586	SS
N30 	Reference T33 UMLS:C0699828	SS
T34	Pharmacological_substance 204 216	psychotropic
N1013 	Reference T34 MeSH:D011619	psychotropic
T40	Combination 421 430	poly-drug
T41	Disorder 889 891	SS
N31 	Reference T41 UMLS:C0024586	SS
N32 	Reference T41 UMLS:C0699828	SS
T47	Disorder 964 966	SS
N33 	Reference T47 UMLS:C0024586	SS
N34 	Reference T47 UMLS:C0699828	SS
T7	Coreferring_mention 307 321	both syndromes
T23	Combination 378 381	and
